Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 264-273

  Kook, Koung Hoon ^a   Choi, Youn Hee ^a,b   Kim, Yu Rim ^a   Park, Soo Jung ^a,c   Jou, Ilo ^a,c   Kim, Sung Joo ^d   Lee, Sang Yeul ^e  

^a Ajou University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Department of Pharmacology ^*  (South Korea)

^d Kim's Eye Hospital   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYALURONIC ACID SYNTHASE; HYALURONIDASE; MESSENGER RNA; PREDNISONE; RADIOACTIVE IODINE; SIALYLTRANSFERASE; SIALYLTRANSFERASE I; SIALYLTRANSFERASE II; THIAMAZOLE; THY 1 ANTIGEN; UNCLASSIFIED DRUG; ALPHA N ACETYLNEURAMINATE ALPHA 2,8 SIALYLTRANSFERASE; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; GANGLIOSIDE; LEUKOCYTE ANTIGEN; SIALOGANGLIOSIDES; ST6GAL1 PROTEIN, HUMAN; TRISIALOGANGLIOSIDE GT1;

ADULT; ANIMAL CELL; ARTICLE; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DECOMPRESSION SURGERY; DIGITAL IMAGING; ENDOCRINE OPHTHALMOPATHY; ENZYME INDUCTION; EXTRACELLULAR SPACE; FEMALE; FIBROBLAST; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR SPACE; LYSOSOME; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MIDDLE AGED; ORBIT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; G(M1) GANGLIOSIDE; GANGLIOSIDES; GRAVES OPHTHALMOPATHY; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; ORBIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALYLTRANSFERASES;

EID: 79952217219     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5276     Document Type: Article

References (49)

1. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-835.
2. Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol. 2006;142:147-153.
3. Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med. 1990;150: 1098-1101.
4. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol. 2002;120:380-386.
5. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010;362:726-738.
6. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology. 1984;91:1411-1419.
7. Perros P, Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab. 1995;9:115-135.
8. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev. 1989;10:366-391.
9. Han R, Smith TJ. T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology. 2006;147:13-19.
10. Wang HS, Tung WH, Tang KT, et al. TGF-beta induced hyaluronan synthesis in orbital fibroblasts involves protein kinase C betaII activation in vitro. J Cell Biochem. 2005;95:256-267.
11. Svennerholm L. The gangliosides. J Lipid Res. 1964;5:145-155.
12. Ruan S, Raj BK, Lloyd KO. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J Neurochem. 1999;72:514-521.
13. Tsuji S. Molecular cloning and functional analysis of sialyltransferases. J Biochem. 1996;120:1-13.
14. Hakomori S. Inaugural article: the glycosynapse. Proc Natl Acad Sci U S A. 2002;99:225-232.
15. Nojiri H, Takaku F, Terui Y, Miura Y, Saito M. Ganglioside GM3: an acidic membrane component that increases during macrophagelike cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc Natl Acad Sci U S A. 1986;83:782-786.
16. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem. 1990;265:18713-18716.
17. Hakomori S, Yamamura S, Handa AK. Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco- (sphingo)lipid-enriched microdomains. Ann N Y Acad Sci. 1998; 845:1-10.
18. Mullin BR, Fishman PH, Lee G, et al. Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A. 1976;73:842-846.
19. Aloj SM, Kohn LD, Lee G, Meldolesi MF. The binding of thyrotropin to liposomes containing gangliosides. Biochem Biophys Res Commun. 1977;74:1053-1059.
20. Kielczynski W, Harrison LC, Leedman PJ. Direct evidence that ganglioside is an integral component of the thyrotropin receptor. Proc Natl Acad Sci U S A. 1991;88:1991-1995.
21. Kielczynski W, Bartholomeusz RK, Harrison LC. Characterization of ganglioside associated with the thyrotrophin receptor. Glycobiology. 1994;4:791-796.
22. Gardas A, Nauman J. Presence of gangliosides in the structure of membrane receptor for thyrotrophin. Acta Endocrinol (Copenh). 1981;98:549-555.
23. Kiljanski J, Ambroziak M, Pachucki J, et al. Thyroid sialyltransferase mRNA level and activity are increased in Graves' disease. Thyroid. 2005;15:645-652.
24. Bieberich E, Yu RK. Multi-enzyme kinetic analysis of glycolipid biosynthesis. Biochim Biophys Acta. 1999;1432:113-124.
25. Natowicz MR, Short MP, Wang Y, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996; 335:1029-1033.
26. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab. 1995;80: 2620-2625.
27. Koumas L, Smith TJ, Phipps RP. Fibroblast subsets in the human orbit: Thy-1+and Thy-1_ subpopulations exhibit distinct phenotypes. Eur J Immunol. 2002;32:477-485.
28. Kannagi R, Levery SB, Hakomori S. Sequential change of carbohydrate antigen associated with differentiation of murine leukemia cells: i-I antigenic conversion and shifting of glycolipid synthesis. Proc Natl Acad Sci U S A. 1983;80:2844-2848.
29. Fenderson BA, Andrews PW, Nudelman E, Clausen H, Hakomori S. Glycolipid core structure switching from globo- to lacto- andganglio-series during retinoic acid-induced differentiation of TERA- 2-derived human embryonal carcinoma cells. Dev Biol. 1987;122: 21-34.
30. Zeng G, Ariga T, Gu XB, Yu RK. Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation. Proc Natl Acad Sci U S A. 1995;92:8670-8674.
31. Yu RK, Bieberich E, Xia T, Zeng G. Regulation of ganglioside biosynthesis in the nervous system. J Lipid Res. 2004;45:783-793.
32. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest. 1999;29:413-425.
33. Rusnati M, Tanghetti E, Urbinati C, et al. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell. 1999;10:313-327.
34. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem. 1963;10:613-623.
35. Bodevin-Authelet S, Kusche-Gullberg M, Pummill PE, DeAngelis PL, Lindahl U. Biosynthesis of hyaluronan: direction of chain elongation. J Biol Chem. 2005;280:8813-8818.
36. Kaback LA, Smith TJ. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 1999;84:4079-4084.
37. Kanda N, Tamaki K. Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells.Immunology. 1999;96:628-633.
38. Kanda N, Watanabe S. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells. J Immunol. 2001;166:72-80.
39. Evanko SP, Wight TN. Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem. 1999;47:1331-1342.
40. Pienimaki JP, Rilla K, Fulop C, et al. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem. 2001;276:20428-20435.
41. Tammi R, Rilla K, Pienimaki JP, et al. Hyaluronan enters keratinocytesby a novel endocytic route for catabolism. J Biol Chem. 2001;276:35111-35122.
42. Dickinson AJ, Gausas RE. Orbital lymphatics: do they exist? Eye. 2006;20:1145-1148.
43. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J. 1988;256:153-158.
44. Smith TJ. Novel aspects of orbital fibroblast pathology. J Endocrinol Invest. 2004;27:246-253.
45. Chen B, Tsui S, Smith TJ. IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol. 2005;175:1310-1319.
46. Young DA, Evans CH, Smith TJ. Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions. Proc Natl Acad Sci U S A. 1998; 95: 8904-8909.
47. Smith TJ, Koumas L, Gagnon A, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2002;87:385-392.
48. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol. 2003;163:1291-1300.
49. Khoo TK, Coenen MJ, Schiefer AR, Kumar S, Bahn RS. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy. Thyroid. 2008;18:1291-1296.